Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.62 USD | -1.91% | +3.82% | -7.78% |
05:57pm | Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating | MT |
15/05 | Transcript : Abeona Therapeutics Inc., Q1 2024 Earnings Call, May 15, 2024 |
Sales 2024 * | 5L 4.17Cr | Sales 2025 * | 2.28Cr 190.46Cr | Capitalization | 19Cr 1.56TCr |
---|---|---|---|---|---|
Net income 2024 * | -5.6Cr -467.27Cr | Net income 2025 * | -5.9Cr -492.3Cr | EV / Sales 2024 * | 373 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 8.18 x |
P/E ratio 2024 * |
-3.46
x | P/E ratio 2025 * |
-3.01
x | Employees | 84 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.91% |
Latest transcript on Abeona Therapeutics Inc.
1 day | -1.91% | ||
1 week | +3.82% | ||
Current month | +11.59% | ||
1 month | -40.46% | ||
3 months | -34.09% | ||
6 months | +9.48% | ||
Current year | -7.78% |
Managers | Title | Age | Since |
---|---|---|---|
Vishwas Seshadri
CEO | Chief Executive Officer | 48 | 01/21/01 |
Michael Amoroso
CHM | Chairman | 46 | 09/20/09 |
Joseph Vazzano
DFI | Director of Finance/CFO | 40 | 14/22/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Alvino
BRD | Director/Board Member | 56 | 01/06/01 |
Faith Charles
BRD | Director/Board Member | 62 | 25/21/25 |
Leila Alland
BRD | Director/Board Member | 61 | 19/21/19 |
Date | Price | Change | Volume |
---|---|---|---|
17/24/17 | 4.62 | -1.91% | 500 741 |
15/24/15 | 4.71 | +12.14% | 1,101,517 |
14/24/14 | 4.2 | -2.33% | 955,320 |
13/24/13 | 4.3 | +2.38% | 534,292 |
10/24/10 | 4.2 | -5.62% | 1,086,831 |
Delayed Quote Nasdaq, May 17, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.78% | 19Cr | |
+33.37% | 4.95TCr | |
+1.55% | 4.26TCr | |
+49.11% | 4.25TCr | |
-4.22% | 2.91TCr | |
+11.57% | 2.66TCr | |
-21.00% | 1.86TCr | |
+7.36% | 1.32TCr | |
+28.30% | 1.25TCr | |
+23.80% | 1.21TCr |
- Stock Market
- Equities
- ABEO Stock